Skip to content

Lantheus Holdings, Inc., 10% owner at Perspective Therapeutics, sold CATX on Sep 3, 2026

Data as of Oct 16

▼ SELL$251K80,783 shares at $3.11Lantheus Holdings, Inc. 10% ownerCATX Perspective Therapeutics, Inc.
Watch CATX
Traded
Sep 3, 2026
Disclosed
Sep 8, 2026
Filed
5 days after the trade · late

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Lantheus Holdings, Inc., 10% owner at Perspective Therapeutics, sold CATX on Sep 3, 2026TRADEDDISCLOSED
CATXSimilar stocks (S&P 500 (SPY)), rebased to CATX's price on the disclosure day
CATX since disclosure
−30.4%
after the sale
Similar stocks (SPY) since disclosure
−0.4%
S&P 500 (SPY)

Change in closing price from Sep 8, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLLantheus Alpha Therapy, LLC 10% ownerCATX Perspective Therapeutics, Inc.$526Kdisclosed Sep 8 · filed 4 days after the trade
  2. ▼ SELLLantheus Holdings, Inc. 10% ownerCATX Perspective Therapeutics, Inc.$526Kdisclosed Sep 8 · filed 4 days after the trade
  3. ▼ SELLLantheus Alpha Therapy, LLC 10% ownerCATX Perspective Therapeutics, Inc.$251Kdisclosed Sep 8 · filed 5 days after the trade · late

See every trade on CATX →